International Journal of Biomedicine. 2023;13(2):188-193.
DOI: 10.21103/Article13(2)_RA1
Originally published June 5, 2023
The periodontal ligament (PDL) contains a unique population of mesenchymal stem cells (MSCs), also known as PDL stem cells (PDLSCs). The regenerative properties of PDLSCs offer much potential for stem cell-based therapy, particularly for periodontal or bone regeneration. Aspirin (ASA) is a widely used nonsteroidal anti-inflammatory drug (NSAID) that has been reported to modulate a variety of diseases, such as cardiovascular, diabetes, and cancer. This review article focuses on the impacts of ASA on various stem cells. First, we will explain what constitutes PDLSCs and their derivation from periodontal tissues. Then we will discuss the mechanisms of ASA and its effect on periodontal tissues. Next, we focus on aspirin’s effects on the differentiation of various types of stem cells. Finally, we investigate the effects of ASA on growth factors that could enhance the osteoblastic potential of derived stem cells.
1. Coura GS, Garcez RC, de Aguiar CB, Alvarez-Silva M, Magini RS, Trentin AG. Human periodontal ligament: a niche of neural crest stem cells. J Periodontal Res. 2008 Oct;43(5):531-6. doi: 10.1111/j.1600-0765.2007.01065.x.
2. Fortino VR, Chen RS, Pelaez D, Cheung HS. Neurogenesis of neural crest-derived periodontal ligament stem cells by EGF and bFGF. J Cell Physiol. 2014 Apr;229(4):479-88. doi: 10.1002/jcp.24468.
3. Marie PJ. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene. 2003 Oct 16;316:23-32. doi: 10.1016/s0378-1119(03)00748-0.
4. Scanlon C, Marchesan J, Soehren S, Matsuo M, Kapila Y. Capturing the regenerative potential of periodontal ligament fibroblasts. J Stem Cells Regen Med. 2011 Apr 1;7(1):54-6. doi: 10.46582/jsrm.0701006.
5. Tomokiyo A, Maeda H, Fujii S, Wada N, Shima K, Akamine A. Development of a multipotent clonal human periodontal ligament cell line. Differentiation. 2008 Apr;76(4):337-47. doi: 10.1111/j.1432-0436.2007.00233.x.
6. Ibi M, Ishisaki A, Yamamoto M, Wada S, Kozakai T, Nakashima A, Iida J, Takao S, Izumi Y, Yokoyama A, Tamura M. Establishment of cell lines that exhibit pluripotency from miniature swine periodontal ligaments. Arch Oral Biol. 2007 Oct;52(10):1002-8. doi: 10.1016/j.archoralbio.2007.04.009.
7. Zhang C, Lu Y, Zhang L, Liu Y, Zhou Y, Chen Y, Yu H. Influence of different intensities of vibration on proliferation and differentiation of human periodontal ligament stem cells. Arch Med Sci. 2015 Jun 19;11(3):638-46. doi: 10.5114/aoms.2015.52370.
8. Huang GT, Gronthos S, Shi S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J Dent Res. 2009 Sep;88(9):792-806. doi: 10.1177/0022034509340867.
9. Lin NH, Gronthos S, Bartold PM. Stem cells and future periodontal regeneration. Periodontol 2000. 2009;51:239-51. doi: 10.1111/j.1600-0757.2009.00303.x.
10. Seo BM, Miura M, Gronthos S, Bartold PM, Batouli S, Brahim J, Young M, Robey PG, Wang CY, Shi S. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet. 2004 Jul 10-16;364(9429):149-55. doi: 10.1016/S0140-6736(04)16627-0.
11. Silvério KG, Rodrigues TL, Coletta RD, Benevides L, Da Silva JS, Casati MZ, Sallum EA, Nociti FH Jr. Mesenchymal stem cell properties of periodontal ligament cells from deciduous and permanent teeth. J Periodontol. 2010 Aug;81(8):1207-15. doi: 10.1902/jop.2010.090729.
12. Xu J, Wang W, Kapila Y, Lotz J, Kapila S. Multiple differentiation capacity of STRO-1+/CD146+ PDL mesenchymal progenitor cells. Stem Cells Dev. 2009 Apr;18(3):487-96. doi: 10.1089/scd.2008.0113.
13. Bosshardt DD, Sculean A. Does periodontal tissue regeneration really work? Periodontol 2000. 2009;51:208-19. doi: 10.1111/j.1600-0757.2009.00317.x.
14. Chang JK, Li CJ, Wu SC, Yeh CH, Chen CH, Fu YC, Wang GJ, Ho ML. Effects of anti-inflammatory drugs on proliferation, cytotoxicity and osteogenesis in bone marrow mesenchymal stem cells. Biochem Pharmacol. 2007 Nov 1;74(9):1371-82. doi: 10.1016/j.bcp.2007.06.047.
15. Chang JK, Wang GJ, Tsai ST, Ho ML. Nonsteroidal anti-inflammatory drug effects on osteoblastic cell cycle, cytotoxicity, and cell death. Connect Tissue Res. 2005;46(4-5):200-10. doi: 10.1080/03008200500344025.
16. Ho ML, Chang JK, Tsai HT, Cho MH, Wang GJ. Nonsteroidal anti-inflammatory drugs arrest cell cycle in G0/G1 phase and induce cell death in osteoblast-enriched cultures. J Musculoskeletal Res. 2001;5:279–289.
17. De Luna-Bertos E, Ramos-Torrecillas J, García-Martínez O, Díaz-Rodríguez L, Ruiz C. Effect of aspirin on cell growth of human MG-63 osteosarcoma line. ScientificWorldJournal. 2012;2012:834246. doi: 10.1100/2012/834246.
18. Ho ML, Chang JK, Chuang LY, Hsu HK, Wang GJ. Effects of nonsteroidal anti-inflammatory drugs and prostaglandins on osteoblastic functions. Biochem Pharmacol. 1999 Sep 15;58(6):983-90. doi: 10.1016/s0006-2952(99)00186-0.
19. Casimiro DR, Cox K, Tang A, Sykes KJ, Feng M, Wang F, Bett A, Schleif WA, Liang X, Flynn J, Tobery TW, Wilson K, Finnefrock A, Huang L, Vitelli S, Lin J, Patel D, Davies ME, Heidecker GJ, Freed DC, Dubey S, O'Connor DH, Watkins DI, Zhang ZQ, Shiver JW. Efficacy of multivalent adenovirus-based vaccine against simian immunodeficiency virus challenge. J Virol. 2010 Mar;84(6):2996-3003. doi: 10.1128/JVI.00969-09.
20. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000;69:145-82. doi: 10.1146/annurev.biochem.69.1.145.
21. Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol Suppl. 1997 Jul;49:15-9.
22. Turini ME, DuBois RN. Cyclooxygenase-2: a therapeutic target. Annu Rev Med. 2002;53:35-57. doi: 10.1146/annurev.med.53.082901.103952.
23. Raisz LG. Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism. J Nutr. 1995 Jul;125(7 Suppl):2024S-2027S. doi: 10.1093/jn/125.suppl_7.2024S.
24. Min YK, Rao Y, Okada Y, Raisz LG, Pilbeam CC. Regulation of prostaglandin G/H synthase-2 expression by interleukin-1 in human osteoblast-like cells. J Bone Miner Res. 1998 Jul;13(7):1066-75. doi: 10.1359/jbmr.1998.13.7.1066.
25. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest. 2002 Jun;109(11):1405-15. doi: 10.1172/JCI15681. Erratum in: J Clin Invest 2002 Oct;110(8):1211.
26. Gray PA, Warner TD, Vojnovic I, Del Soldato P, Parikh A, Scadding GK, Mitchell JA. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors. Br J Pharmacol. 2002 Dec;137(7):1031-8. doi: 10.1038/sj.bjp.0704927.
27. Wang Y, He G, Tang H, Shi Y, Zhu M, Kang X, Bian X, Lyu J, Zhou M, Yang M, Mu M, Chen W, Zhou B, Yuan C, Zhang J, Tang K. Aspirin promotes tenogenic differentiation of tendon stem cells and facilitates tendinopathy healing through regulating the GDF7/Smad1/5 signaling pathway. J Cell Physiol. 2020 May;235(5):4778-4789. doi: 10.1002/jcp.29355.
28. Abd Rahman F, Mohd Ali J, Abdullah M, Abu Kasim NH, Musa S. Aspirin Enhances Osteogenic Potential of Periodontal Ligament Stem Cells (PDLSCs) and Modulates the Expression Profile of Growth Factor-Associated Genes in PDLSCs. J Periodontol. 2016 Jul;87(7):837-47. doi: 10.1902/jop.2016.150610.
29. Abd Rahman F. Gene expression profiling on effect of aspirin on osteogenic differentiation of periodontal ligament stem cells. BDJ Open. 2021 Sep 16;7(1):35. doi: 10.1038/s41405-021-00090-5.
30. Xie Y, Pan M, Gao Y, Zhang L, Ge W, Tang P. Dose-dependent roles of aspirin and other non-steroidal anti-inflammatory drugs in abnormal bone remodeling and skeletal regeneration. Cell Biosci. 2019 Dec 23;9:103. doi: 10.1186/s13578-019-0369-9.
31. Yuan M, Zhan Y, Hu W, Li Y, Xie X, Miao N, Jin H, Zhang B. Aspirin promotes osteogenic differentiation of human dental pulp stem cells. Int J Mol Med. 2018 Oct;42(4):1967-1976. doi: 10.3892/ijmm.2018.3801.
32. Cao Y, Xiong J, Mei S, Wang F, Zhao Z, Wang S, Liu Y. Aspirin promotes bone marrow mesenchymal stem cell-based calvarial bone regeneration in mini swine. Stem Cell Res Ther. 2015 Oct 31;6:210. doi: 10.1186/s13287-015-0200-4.
33. Heasman PA, Hughes FJ. Drugs, medications and periodontal disease. Br Dent J. 2014 Oct;217(8):411-9. doi: 10.1038/sj.bdj.2014.905.
34. Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Ngianga-Bakwin K, Grove A, Gurung B, Morrow S, Stranges S, Clarke A. Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials. PLoS One. 2013 Dec 5;8(12):e81970. doi: 10.1371/journal.pone.0081970.
35. Zhang Y, Ding N, Zhang T, Sun Q, Han B, Yu T. A Tetra-PEG Hydrogel Based Aspirin Sustained Release System Exerts Beneficial Effects on Periodontal Ligament Stem Cells Mediated Bone Regeneration. Front Chem. 2019 Oct 17;7:682. doi: 10.3389/fchem.2019.00682.
36. Cao Y, Xiong J, Mei S, Wang F, Zhao Z, Wang S, Liu Y. Aspirin promotes bone marrow mesenchymal stem cell-based calvarial bone regeneration in mini swine. Stem Cell Res Ther. 2015 Oct 31;6:210. doi: 10.1186/s13287-015-0200-4.
37. Zafarmand SS, Karimi-Haghighi S, Salehi MS, Hooshmandi E, Owjfard M, Bayat M, Karimlou S, Pandamooz S, Dianatpour M, Borhani-Haghighi A. Aspirin impacts on stem cells: Implications for therapeutic targets. Tissue Cell. 2022 Feb;74:101707. doi: 10.1016/j.tice.2021.101707.
38. Dailey L, Ambrosetti D, Mansukhani A, Basilico C. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 2005 Apr;16(2):233-47. doi: 10.1016/j.cytogfr.2005.01.007.
39. Miraoui H, Oudina K, Petite H, Tanimoto Y, Moriyama K, Marie PJ. Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling. J Biol Chem. 2009 Feb 20;284(8):4897-904. doi: 10.1074/jbc.M805432200.
40. Tang J, Xiong J, Wu T, Tang Z, Ding G, Zhang C, Wang S, Liu Y. Aspirin treatment improved mesenchymal stem cell immunomodulatory properties via the 15d-PGJ2/PPARγ/TGF-β1 pathway. Stem Cells Dev. 2014 Sep 1;23(17):2093-103. doi: 10.1089/scd.2014.0081.
41. Hurley MM, Marie PJ, Florkiewicz RZ. Fibroblast growth factor (FGF) and FGF receptor families in bone. In book: Principles of Bone Biology; 2002: pp. 825–851.
42. Yun YR, Won JE, Jeon E, Lee S, Kang W, Jo H, Jang JH, Shin US, Kim HW. Fibroblast growth factors: biology, function, and application for tissue regeneration. J Tissue Eng. 2010 Nov 7;2010:218142. doi: 10.4061/2010/218142.
43. Rodrigues M, Griffith LG, Wells A. Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther. 2010 Oct 26;1(4):32. doi: 10.1186/scrt32.
44. Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E, Takagishi K, Kato Y. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun. 2001 Oct 26;288(2):413-9. doi: 10.1006/bbrc.2001.5777.
45. Pitaru S, Kotev-Emeth S, Noff D, Kaffuler S, Savion N. Effect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells: enhanced development of mineralized bone-like tissue in culture. J Bone Miner Res. 1993 Aug;8(8):919-29. doi: 10.1002/jbmr.5650080804.
46. Hanada K, Dennis JE, Caplan AI. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res. 1997 Oct;12(10):1606-14. doi: 10.1359/jbmr.1997.12.10.1606.
47. Ohbayashi N, Shibayama M, Kurotaki Y, Imanishi M, Fujimori T, Itoh N, Takada S. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 2002 Apr 1;16(7):870-9. doi: 10.1101/gad.965702.
48. Kubota K, Iseki S, Kuroda S, Oida S, Iimura T, Duarte WR, Ohya K, Ishikawa I, Kasugai S. Synergistic effect of fibroblast growth factor-4 in ectopic bone formation induced by bone morphogenetic protein-2. Bone. 2002 Oct;31(4):465-71. doi: 10.1016/s8756-3282(02)00852-9.
49. Ling L, Murali S, Dombrowski C, Haupt LM, Stein GS, van Wijnen AJ, Nurcombe V, Cool SM. Sulfated glycosaminoglycans mediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cells. J Cell Physiol. 2006 Dec;209(3):811-25. doi: 10.1002/jcp.20760.
50. Tokuda H, Kozawa O, Uematsu T. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase. J Bone Miner Res. 2000 Dec;15(12):2371-9. doi: 10.1359/jbmr.2000.15.12.2371.
51. Hurley MM, Abreu C, Marcello K, Kawaguchi H, Lorenzo J, Kalinowski J, Ray A, Gronowicz G. Regulation of NFIL-6 and IL-6 expression by basic fibroblast growth factor in osteoblasts. J Bone Miner Res. 1996 Jun;11(6):760-7. doi: 10.1002/jbmr.5650110607.
52. Kawaguchi H, Pilbeam CC, Gronowicz G, Abreu C, Fletcher BS, Herschman HR, Raisz LG, Hurley MM. Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. J Clin Invest. 1995 Aug;96(2):923-30. doi: 10.1172/JCI118140.
53. Varghese S, Rydziel S, Canalis E. Basic fibroblast growth factor stimulates collagenase-3 promoter activity in osteoblasts through an activator protein-1-binding site. Endocrinology. 2000 Jun;141(6):2185-91. doi: 10.1210/endo.141.6.7504.
Download Article
Received March 13, 2023.
Accepted May 20, 2023.
©2023 International Medical Research and Development Corporation.
